Stock data
ALX Oncology Holdings Inc. (ALXO)
ALX Oncology Holdings Inc. (ALXO) reported net income of -US$101.69M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$104.02M | -US$101.69M | — |
| 2024 | — | — | -US$142.47M | -US$134.85M | — |
| 2023 | — | — | -US$170.28M | -US$160.81M | — |
| 2022 | US$0.00M | — | -US$127.44M | -US$123.48M | — |
| 2021 | US$0.00M | — | -US$83.56M | -US$83.46M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$17.97M | — |
| 2026-03-31 | — | -US$17.93M | — |
| 2025-12-31 | — | -US$22.85M | — |
| 2025-09-30 | — | -US$22.14M | — |
| 2025-06-30 | — | -US$25.95M | — |
| 2025-03-31 | — | -US$30.75M | — |
| 2024-12-31 | — | -US$29.16M | — |
| 2024-09-30 | — | -US$30.71M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.